Theravance Biopharma (TBPH) Amortizatization of Intangibles (2015 - 2026)

Theravance Biopharma (TBPH) has reported Amortizatization of Intangibles for 5 consecutive years, with $341000.0 the latest figure, recorded in Q1 2022.

• In Q1 2022, Amortizatization of Intangibles fell 54.1% year-over-year to $341000.0; the TTM figure through Mar 2022 stood at $3.4 million (down 6.78% YoY), while the FY2021 annual figure was $3.8 million, up 13.22% from the prior year.
• Amortizatization of Intangibles eased to $341000.0 in Q1 2022 per TBPH's latest filing, from $1.0 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $1.1 million in Q4 2020 and bottomed at $195000.0 in Q4 2019.
• Historically, Amortizatization of Intangibles has averaged $822692.3 across 4 years, with a median of $986000.0 in 2019.
• Annual changes were most pronounced in 2020 — Amortizatization of Intangibles soared 480.0% — and 2022, when it sank 54.1%.
• Theravance Biopharma's Amortizatization of Intangibles stood at $195000.0 in 2019, then jumped by 480.0% to $1.1 million in 2020, then fell by 9.11% to $1.0 million in 2021, then slumped by 66.83% to $341000.0 in 2022.
• Business Quant data shows TBPH's Amortizatization of Intangibles at $341000.0 in Q1 2022, $1.0 million in Q4 2021, and $1.0 million in Q3 2021.